Derivatives of purine, process for their preparation and a pharmaceutical preparation
US5565461A · kind A · utility
7Cited by
4References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 3, 1995 |
| Grant date | Oct 15, 1996 |
| Priority date | — |
| Expiry date | Apr 3, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/657181
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention is directed to a method of treating an HIV infection in a host in need of such treatment which comprises administering an effective anti-HIV amount of a compound having the formula ##STR1## wherein: R.sup.1 is hydrogen, hydroxyl; PA1 R.sup.2 is amino; PA1 R.sup.3 and R.sup.4 are independently selected from hydroxyl or an ester residue of said hydroxyl group derived from R.sup.6 COOH, wherein R.sup.6 is hydrogen, or C.sub.1 -C.sub.3 alkyl; and n is 1; or a pharmaceutically acceptable salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.